Business Context and Reporting Period
This Form 8-K reports on the 2011 annual meeting of stockholders for Ventrus Biosciences, Inc. (note: the metadata lists "Assembly Biosciences, Inc." but the filing text identifies the registrant as Ventrus Biosciences, Inc.). The meeting was held on May 19, 2011.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and voting results.
Material Changes and Voting Results
Board of Directors Election
Stockholders elected five members to the board of directors for a term expiring in 2012. The voting results were as follows:
| Director | Voted For | Against/Withheld | Broker Non-Votes |
|---|---|---|---|
| Mark Auerbach | 3,528,540 | 6,505 | 1,574,621 |
| Russell H. Ellison | 3,528,440 | 6,605 | 1,574,621 |
| Joseph Felder | 3,528,540 | 6,505 | 1,574,621 |
| Myron Z. Holubiak | 3,528,540 | 6,505 | 1,574,621 |
| Thomas Rowland | 3,528,540 | 6,505 | 1,574,621 |
Equity Incentive Plan Amendment
Stockholders approved an amendment to the 2010 Equity Incentive Plan to increase the number of shares reserved for issuance from 2,467,200 to 3,967,200 shares.
- For: 3,411,291 shares
- Against/Abstained: 119,754 shares
- Broker Non-Votes: 1,574,621 shares
Appointment of Independent Auditor
Stockholders ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2011.
- For: 3,517,143 shares
- Against/Abstained: 13,902 shares
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the correct registrant name (Ventrus Biosciences, Inc.) versus the metadata provided (Assembly Biosciences, Inc.).
- Confirm the impact of the increased share reserve (3,967,200 shares) on potential future dilution.
- Note the significant number of broker non-votes (1,574,621) across all proposals, indicating shares held in street name where brokers lacked discretionary voting power.
- Confirm the tenure of the newly elected board members, which expires at the 2012 annual meeting.